Clinical Trials Directory

Trials / Completed

CompletedNCT01073059

Pharmacokinetic Interactions in Combination Treatment of Valproic Acid and Ertapenem in Normal Subjects

Open-label, Two-period, One Sequence, Multiple Dose, Crossover Study, A Study to Investigate Pharmacokinetic Interactions in Combination Treatment of Valproic Acid and Ertapenem in Normal Healthy Male Subjects

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
10 (actual)
Sponsor
Chonbuk National University · Academic / Other
Sex
Male
Age
19 Years – 50 Years
Healthy volunteers
Accepted

Summary

* This trial is conducted to assess pharmacokinetic characteristics of valproic acid when valproic acid single treatment and valproic acid \& ertapenem combination treatment * This trial is performed to evaluate safety of the combination treatment compare with single treatment * The investigators carry this trial out to study mechanism of combination treatment

Conditions

Interventions

TypeNameDescription
DRUGValproic acid and Ertapenem

Timeline

Start date
2009-08-01
First posted
2010-02-23
Last updated
2010-12-08

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01073059. Inclusion in this directory is not an endorsement.

Pharmacokinetic Interactions in Combination Treatment of Valproic Acid and Ertapenem in Normal Subjects (NCT01073059) · Clinical Trials Directory